Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03875326 · ClinicalTrials.gov registry record · NA
Stimulation to Improve Memory
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 233
- Enrollment target
NCT03875326: Completed NA study, sponsored by University of Michigan.
NCT03875326 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 233 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03875326, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 233 participants
- Enrollment target
Study Summary
This study will test the effects of different doses of a form of non-invasive brain stimulation for the treatment of individuals with mild cognitive impairment (MCI) and dementia of the Alzheimer's Type (DAT).
Primary Outcome
Primary outcome focuses on default mode network (DMN) between-network functional connectivity because the lateral temporal cortex is a core component of the DMN. Between-network functional connectivity is estimated from fMRI data as strength of temporal coupling between the DMN and other high-level (association) brain networks. For each participant and time point, correlation-based connectivity (Pearson r; Fisher r-to-z transformed; arbitrary units) computed between DMN regions and other regions
Interventions
- DEVICE Sham
- DEVICE 1 mA HD-tDCS
- DEVICE 2 mA HD-tDCS
- DEVICE 3 mA HD-tDCS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 233 participants |
| Start Date | 2019-04-01 |
| Est. Completion | 2024-12-19 |
| Phase | NA |
What the finished NCT03875326 record still lists
NCT03875326 is an interventional study that assigns participants to a tested intervention. The registered 233 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 4 interventions - of which Sham is the first listed.
NCT03875326 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03875326 about?
NCT03875326 is a clinical study titled "Stimulation to Improve Memory". This study will test the effects of different doses of a form of non-invasive brain stimulation for the treatment of individuals with mild cognitive impairment (MCI) and dementia of the Alzheimer's Type (DAT).
What is the current status of trial NCT03875326?
This trial is currently completed. It is a NA study. The enrollment target is 233 participants. The study started on 2019-04-01. Estimated completion is 2024-12-19.
What interventions are being tested in trial NCT03875326?
The interventions under investigation include: Sham (DEVICE), 1 mA HD-tDCS (DEVICE), 2 mA HD-tDCS (DEVICE), 3 mA HD-tDCS (DEVICE).
Who is sponsoring clinical trial NCT03875326?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03875326's enrollment target sits among peer trials
233 463rd of 2000 higher than 1,538 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06993844 · 233 participants · Phase 1
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
- NCT07141706 · 233 participants · Phase 1
A Study of DB-1317 in Selected Advanced/Metastatic Solid Tumors
- NCT04942717 · 234 participants · NA
Adapting for Latinx Populations an Intervention That Involves Discussing and Sharing Patients' Health-Related Values
- NCT05208671 · 234 participants · NA
Nutrition to Optimize, Understand, and Restore Insulin Sensitivity in HIV for Oklahoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI